MedPath

LEVOSIMENDAN CARINOPHARM 12,5 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

LEVOSIMENDAN CARINOPHARM 12,5 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Pending
Register Number

86126

Prescription Type

Uso Hospitalario

Authorization Date

Oct 8, 2021

Dosage Form

POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number86126
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

LEVOSIMENDANActive
Quantity: 12,5 mg
Name: LEVOSIMENDAN

ATC CLASSIFICATION (3)

C01C
C01CX
C01CX08

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.